Skin Conditioning
TRANEXAMOYL DIPEPTIDE-33
Safety score · 0–100
Good
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
A dipeptide conjugate of tranexamic acid — designed to nudge melanin pathways for a more even tone. Topically benign at cosmetic levels; the prescription-drug status of tranexamic acid applies to systemic dosing only.
Function
Skin benefits
- Targeted skin-tone evening
- Tranexamic-acid-derived brightening
- Combines with peptide signalling
- Generally well tolerated
Known concerns
- Tranexamic acid is a prescription drug at systemic doses (not relevant topically)
- Limited independent cosmetic clinical data
- Rare peptide allergy
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Related skin conditionings
Check your shelf
Find TRANEXAMOYL DIPEPTIDE-33 in your products.
Scan any cosmetic product with LuxSense to see if it contains TRANEXAMOYL DIPEPTIDE-33 and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.